Table 4 |
|||||
| Association between race and using treatment approaches among participants with radiographic-confirmed knee osteoarthritis (N = 2583) | |||||
| Treatment Use | African Americans | Caucasian Americans | Crude | Sociodemographic Characteristics Adjusted† | Sociodemographic and Clinical Characteristics Adjusted‡ |
| (n = 508) | (n = 2075) | ||||
| percentage | Odds ratios of African Americans relative to Caucasian Americans (95% confidence intervals) | ||||
| CAM Only | 16.5 | 24.2 | 0.76 | 0.77 | 0.68 |
| (0.57–1.01) | (0.56–1.06) | (0.48–0.96) | |||
| Conventional Medication Only | 24.8 | 14.6 | 1.89 | 1.57 | 0.96 |
| (1.45–2.46) | (1.16–2.15) | (0.68–1.35) | |||
| Both | 25.0 | 23.8 | 1.17 | 1.11 | 0.59 |
| (0.91–1.51) | (0.83–1.49) | (0.42–0.83) | |||
| Neither | 33.7 | 37.5 | Reference group of outcome variable | ||
† Adjusted sociodemographics include age, gender, education, income, marital status and medication insurance coverage.
‡ Besides sociodemographic variables, full model also adjusted KOOS Pain and Quality of Life subscales, Kellgren-Lawrence Grade, history of knee injury or surgery, symptom-related multi-joint osteoarthritis, SF-12 mental health scale, SF-12 physical health scale and obesity status.
Yang et al. BMC Complementary and Alternative Medicine 2012 12:86 doi:10.1186/1472-6882-12-86
